Nomic

Montréal, Canada

Nomic develops a proteomic technology platform to understand, detect, and treat diseases with DNA nanotechnology.

$42.0M raised

Sep 2024

Series B

Top Investors

Y CombinatorLux CapitalSR OneAvant BioFirst Star Ventures

19,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Nomic raised?

Nomic has raised $42.0M in total funding. The most recent round was Series B. The last funding was announced in September 2024.

Who are Nomic's investors?

Nomic's investors include Y Combinator, Lux Capital, SR One, Avant Bio, First Star Ventures.

Where is Nomic headquartered?

Nomic is headquartered in Montréal, Canada.

What does Nomic do?

Nomic develops a proteomic technology platform to understand, detect, and treat diseases with DNA nanotechnology.

What stage is Nomic at?

Nomic is at the Series B stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated September 17, 2024.

MLA

"Nomic — Funding & Investors." VCBacked, September 17, 2024, https://www.vcbacked.co/company/nomic. Accessed June 4, 2026.

APA

VCBacked. (2024). Nomic — Funding & Investors. Retrieved June 4, 2026, from https://www.vcbacked.co/company/nomic

Wikipedia (cite web)

{{cite web |title=Nomic — Funding & Investors |url=https://www.vcbacked.co/company/nomic |website=VCBacked |access-date=June 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated September 17, 2024.